Riverfield plans to have its device on the Japanese market by 2020.
Robot-assisted surgery startup Riverfield Surgical Robot Laboratory reportedly raised more than $10 million (¥1.15 billion) for the Emaro robot-assisted surgery platform it’s developing.
Based on technology developed at the Tokyo Institute of Technology, Riverfield plans to have its device on the Japanese market by 2020, selling at half the price of the da Vinci robot marketed by industry behemoth Intuitive Surgical (NSDQ:ISRG), the Nikkei Asian Review reported.
Unlike other robotic surgery systems that are powered by electric motors, the Riverfield system uses pneumatics to drive its robotic arm.
